文献速递皮肤肿瘤

黑色素瘤死亡率在高效疗法普及前已呈减速趋势:差异时间序列分析

Differential time series analysis shows deceleration in melanoma mortality prior to the widespread use of highly effective therapies.
PubMed 文献 · J Am Acad Dermatol · 2024-07-20

该研究基于美国与澳大利亚人群黑色素瘤死亡率数据,采用差异时间序列分析模型,发现两国黑色素瘤死亡率自20世纪70年代起显著减速,美国约2001年、澳大利亚约2004年出现零加速度拐点,提示在现代疗法普及前公共卫生干预已发挥作用。

要点

  • 零加速度拐点美国约2001年(95%CI 1996-2008),澳大利亚约2004年(95%CI 1999-2011)。
  • 两国男性死亡率减速速度是女性的3-4倍。

研究设计与样本

  • 基于美国与澳大利亚人群 ascertained 黑色素瘤死亡率数据的差异时间序列分析,覆盖1969-2014年。
  • 将黑色素瘤死亡率轨迹与另外10种癌症的轨迹进行建模比较。

主要发现

  • 美国黑色素瘤死亡率自1970年代显著减速(P<.0001),澳大利亚同样显著(P=.0021)。
  • 零加速度出现时间:美国约2001年(95%CI:1996,2008),澳大利亚约2004年(95%CI:1999,2011)。
  • 两国男性死亡率减速速度是女性的3-4倍。
  • 黑色素瘤死亡率遵循与其他10种癌症相似的二次函数(R2>0.9),但拐点更晚(1986 vs 2001)且焦点宽度更宽。

临床怎么用

  • 提示皮肤科医生应重视早期筛查与公共卫生宣教对降低黑色素瘤死亡率的潜在贡献。

局限性

  • 使用绝对死亡率数据,未进一步分层或考虑癌症发病率或协变量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although the recent drop in melanoma mortality has been attributed to the introduction of newer therapies, the impact of ongoing public efforts remains unknown. OBJECTIVE: Characterize and model melanoma mortality trends before the era of molecular and immune therapies (1969-2014) in the U.S. and Australia. METHODS: Differential time series analysis based on population-ascertained melanoma mortality rates from the U.S. and Australia. Mortality rates were modeled and compared to the trajectories of ten other cancers. RESULTS: Melanoma mortality rates have been significantly decelerating since the 1970s in both the U.S. (P < .0001) and Australia (P = .0021). Zero acceleration occurred around 2001 (95% CI: 1996, 2008) for the U.S. and 2004 (95% CI: 1999, 2011) for Australia. Male mortality rates decelerated 3x-4x faster than females in both countries. Melanoma mortality followed a similar quadratic function (R2 > 0.9) to 10 other cancers, albeit with a later inflection point (1986 vs 2001) and broader focal width. LIMITATIONS: Absolute mortality data used without further stratification or considering cancer incidence or covariates. CONCLUSION: Melanoma deaths have been decelerating for the past 5 decades, reaching an inflection point around 2001, suggesting that mitigating campaigns were already afoot in both the U.S. and Australia before the advent of modern therapies.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Latoni DI, Semenov YR, Tsao H, et al. Differential time series analysis shows deceleration in melanoma mortality prior to the widespread use of highly effective therapies. J Am Acad Dermatol. 2024. PMID: 39038555. doi:10.1016/j.jaad.2024.07.1457

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。